More recently, in a mouse model of ovarian cancer, Th1 cell differentiation of CD4+ T cells was found to be increased after treatment with artesunate, a promoter of microRNA-142 expression that downregulates Sirt1 expression, again confirming the suppressive role of Sirt1 in Th1 cell differentiation63. Here, SIRT1 is linked to ovarian carcinoma.